Abbott is working to correct the problem. Users can visit the FreeStyleCheck website to see if their sensors are affected and ...

Crucially, type 1 diabetes is not related to diet and lifestyle choices. As the Diabetes UK website outlines, the exact ...

Now you can control your smart home devices with gestures in addition to button presses. The Flic Duo delivers twice the ...

Abbott Laboratories (NYSE: ABT) doesn’t just pay dividends. It grows them. For 52 consecutive years. That’s Dividend King ...

Diabetes Care and CamDiab are pleased to announce that Health Canada has approved the use of mylife Loop powered by mylife ...

VO2 max is an intimidating word for an easy-to-understand biometric: It’s how well your body uses oxygen when you push ...

MiniMed Go is the first and only smart MDI system that automatically integrates insulin dosing and glucose data in a single app to provide empowering insights for individuals on multiple daily ...

Abbott's (NYSE: ABT) newest sensor-based glucose technology, the FreeStyle Libre 3 Plus* sensor, is now publicly funded in ...

Libre Assist 1 uses generative AI to predict how a food choice may affect a person’s glucose levels. 2 It then offers ...

Abbott is tapping the spirit of new beginnings for the New Year by unveiling a “gamechanger" feature within the company’s ...